05 Compliance

The regulatory file for L-ornithine

Technical document 05 · Reviewed 2026-11-19 · L-Ornithine

On this page
  1. The file, not the certificate
  2. The European Union: an amino acid, not a listed vitamin
  3. The United States: the dietary-ingredient route
  4. Contaminants: the drum figure and the finished dose
  5. Claims, the panel and the form trap
  6. What the file must contain
  7. Review points before the first order

L-ornithine sits outside the EU's harmonised vitamin and mineral lists, so a supplement that contains it depends on general food law plus whatever the destination member state requires for amino acids. The US route is the dietary-ingredient route; Great Britain keeps its own framework and Northern Ireland follows the EU. Whether the powder may be sold is only the first question: the contaminant ceiling, the label and the claim each need separate evidence.

In one line

The specification characterises the powder; the regulatory file has to connect it to a route, a ceiling and a label for the destination, and the buyer's team signs that route off.

The file, not the certificate

A supplier can hand over a certificate, a specification and a safety data sheet without ever answering the market question. The file has to connect those documents to an instrument, a destination and a finished-product dose.

Instruments that decide an L-ornithine supplement file
MarketInstrumentsWhat they decide
European UnionDirective 2002/46/EC; Regulations 178/2002, 2015/2283, 2023/915, 1169/2011 and 1924/2006Supplement status, novel-food history, contaminants, labelling and claims
United StatesFD&C Act section 201(ff) as amended by DSHEA; 21 CFR 111, 101.36, 101.93 and 190.6Dietary-ingredient basis, cGMP, Supplement Facts and structure/function statements
United KingdomRetained food law, including the 2003 supplement rules and the 2014 food information rulesSale and labelling in Great Britain; Northern Ireland uses the EU regime

The certificate is a lot document, not an authorisation. The specification describes the material. The safety data sheet describes handling. None of the three speaks for the destination, and the buyer's regulatory team is the party that closes that gap.

The European Union: an amino acid, not a listed vitamin

Directive 2002/46/EC harmonises the vitamins and minerals that may be used in food supplements. Annexes I and II do not include ornithine, so the member state where the product is sold decides whether a maximum level, a notification or a form restriction applies. The same capsule can be routine in one country and need a filing in another.

Novel food is a separate gate. Regulation (EU) 2015/2283 turns on documented use before 15 May 1997; the file needs the evidence behind that claim, not just the conclusion. The free base, CAS 70-26-8, and the hydrochloride, CAS 3184-13-2, are separate materials, so a document written for one does not cover the other.

The label rules come from Regulation (EU) No 1169/2011 and the Directive's supplement particulars. Ornithine has no Nutrient Reference Value, so a percentage of an NRV has no basis. Contaminants fall under Regulation (EU) 2023/915. Great Britain applies the retained framework, while Northern Ireland remains inside the EU regime.

The United States: the dietary-ingredient route

Section 201(ff) of the FD&C Act allows an amino acid to be sold as a dietary ingredient. The lawful basis is either marketing before 15 October 1994 or a new dietary ingredient notification under 21 CFR 190.6. The supplier should name the basis it relies on; the buyer checks that the basis covers the finished product and the intended use.

Identity testing of each component is the manufacturer's duty under 21 CFR 111. The Supplement Facts panel follows 21 CFR 101.36: it declares the amount per serving, and because ornithine has no Daily Value, no percentage appears beside it.

A structure or function statement needs substantiation and the disclaimer in 21 CFR 101.93; it must stop short of a disease-related claim. The FDA does not clear a label before sale, so the substantiation file is the brand's defence, not the supplier's certificate.

Contaminants: the drum figure and the finished dose

The catalog limits are specification terms. Three of them sit exactly on an EU maximum, which leaves no room for analytical uncertainty.

Catalog limits and the EU position for a food supplement
ElementCatalog limitEU ceiling at this review
Lead (Pb)≤3 mg/kg3.0 mg/kg; the catalog exactly meets it
Cadmium (Cd)≤1 mg/kg1.0 mg/kg maximum; the catalog is at the ceiling
Mercury (Hg)≤0.1 mg/kg0.10 mg/kg maximum; the catalog is at the ceiling
Arsenic (As)≤2 mg/kgNo EU-wide supplement maximum; contractual only

A compliant powder can still fail the finished product. The daily dose, the number of servings and the other ingredients all add to the exposure, so the calculation belongs in the file. In the US, as of this review, no federal lead ceiling applies to supplements; California's Proposition 65 works from the daily dose, using a 0.5 µg/day maximum allowable dose level and a 15 µg/day no-significant-risk level for lead.

Claims, the panel and the form trap

In the EU and the UK, Regulation (EC) No 1924/2006 governs health claims, and a wording must be in the register before it is used. As of this review the register has no authorised claim for L-ornithine; the 2011 EFSA opinion on the urea-cycle claim, ID 4270, concluded that the relationship was not established. The current register is the reference, not this summary.

The US allows a structure or function statement with the DSHEA disclaimer, provided the brand holds substantiation. A compositional statement such as “L-ornithine 500 mg per capsule” is a different thing: it describes the product and has to match the certificate, but it does not authorise a health claim.

The form is where labels fail. A panel that says “L-ornithine” but is filled with the hydrochloride overstates the ornithine by about 21.6% of the salt weight, because the salt is only about 78.4% ornithine. The grades page sets out the conversion.

What the file must contain

  • A lot certificate with the method, the calculation entity and the basis beside each result; the lot code must match the pack.
  • The current specification, naming the free base or the hydrochloride and the mesh.
  • A safety data sheet, an allergen statement and a food-contact declaration for the pouch or liner.
  • A manufacturer and country-of-origin statement that names the actual production site.
  • EU novel-food evidence for the pre-1997 use, not a one-line conclusion.
  • A US statement of the dietary-ingredient basis, or the notification for a new form.
  • A stability summary, the shelf life in force, and any halal or kosher certificate.

Review points before the first order

  1. Name the destination, and for the EU the member state.
  2. Confirm the label and specification both say free base, or both say hydrochloride.
  3. Find the destination's level and notification rule; do not assume the EU position covers it.
  4. Convert every contaminant limit to the finished daily dose and record the margin.
  5. Check the declared quantity against the form and the assay basis.
  6. Search the current claims register or review the US substantiation file.
  7. Keep one version across the specification, the certificate and the artwork.

The US page, the EU regulatory page and the UK page set out the frameworks. Release tests are on the COA page, identity evidence on the identity page and the catalog specification on the product page; the quality page describes the release file.

Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.

Request a quotation